dr. reddy's labs glp-1 receptor agonist medications has just launched Obeda, India's first DCGI-approved generic semaglutide injection for Type 2 diabetes, at just ₹4,200/month Indian drugmaker Dr Reddy's Laboratories
Pay in 4 interest-free payments of $6.14 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5























